Exhibit 99.1 ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update 1Q 2025 Total Revenue of $114.8 Million (Adjusted Total Revenue (1) of$118.6 Million), a 40% YoY Increase 1Q 2025 GAAP Net Income of $26.9 Million, a 51$47.9 Million, an 81% YoY Increase 1Q 2025 Adjusted Net Income (3) of $33.3 Million, an 87$171 Million FDA Approved Yield Enhancement Proc ...